Liven Pharma Limited (PSX:LIVEN)
Pakistan · Delayed Price · Currency is PKR 34.80
-0.07 (-0.20%)
At close: Aug 20, 2026
Liven Pharma Balance Sheet
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 178.8 | 7.88 | 24.96 | 0.03 | 0.03 | 0.05 |
Cash & Short-Term Investments | 178.8 | 7.88 | 24.96 | 0.03 | 0.03 | 0.05 |
Cash Growth | 191571.23% | -68.41% | 92385.38% | 0.20% | -44.73% | -12.81% |
Receivables | 4.27 | 9.4 | 101.02 | - | - | - |
Inventory | 119.92 | 123.32 | 123.78 | - | - | - |
Prepaid Expenses | - | 0.06 | 0.07 | - | - | - |
Other Current Assets | 3.14 | 7.28 | 10.45 | - | - | 0.4 |
Total Current Assets | 306.12 | 147.95 | 260.28 | 0.03 | 0.03 | 0.45 |
Property, Plant & Equipment | 667.52 | 666.51 | 665.55 | 131.45 | 144.55 | 159.1 |
Other Intangible Assets | 8.78 | 8.44 | 1.4 | - | - | - |
Other Long-Term Assets | - | - | - | 0.03 | 0.03 | 0.03 |
Total Assets | 982.42 | 822.9 | 927.23 | 131.5 | 144.6 | 159.58 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Accounts Payable | 32.69 | 38.7 | 14.03 | - | 0 | 0.07 |
Accrued Expenses | 23.93 | 21.8 | 5.4 | 0.78 | 0.92 | 0.55 |
Short-Term Debt | 19.98 | 25.23 | 155.16 | 237.62 | 235.35 | 233.11 |
Current Portion of Long-Term Debt | 2.77 | 2.5 | 0.29 | - | - | - |
Current Portion of Leases | 0.65 | 0.59 | 0.4 | - | - | - |
Other Current Liabilities | 0.79 | 1.61 | 1.2 | - | - | - |
Total Current Liabilities | 80.81 | 90.43 | 176.48 | 238.4 | 236.27 | 233.74 |
Long-Term Debt | 3.21 | 5.1 | 1.06 | - | - | - |
Long-Term Leases | 0.75 | 1.25 | - | - | - | - |
Long-Term Deferred Tax Liabilities | 69.69 | 92.27 | - | 15.72 | 18.62 | 21.84 |
Total Liabilities | 154.46 | 189.04 | 177.54 | 254.12 | 254.89 | 255.58 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Common Stock | 1,130 | 930.4 | 0.4 | 121.24 | 121.24 | 121.24 |
Retained Earnings | -302.45 | -296.54 | 159.78 | -288.3 | -283.07 | -276.67 |
Comprehensive Income & Other | - | - | 589.51 | 44.44 | 51.54 | 59.43 |
Shareholders' Equity | 827.96 | 633.86 | 749.69 | -122.62 | -110.29 | -96 |
Total Liabilities & Equity | 982.42 | 822.9 | 927.23 | 131.5 | 144.6 | 159.58 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Total Debt | 27.37 | 34.67 | 156.91 | 237.62 | 235.35 | 233.11 |
Net Cash (Debt) | 151.43 | -26.78 | -131.95 | -237.59 | -235.32 | -233.06 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | 1.68 | -0.38 | -3298.85 | -19.60 | -19.41 | -19.22 |
Filing Date Shares Outstanding | 113.04 | 93.04 | 12.12 | 12.12 | 12.12 | 12.12 |
Total Common Shares Outstanding | 113.04 | 93.04 | 12.12 | 12.12 | 12.12 | 12.12 |
Working Capital | 225.31 | 57.53 | 83.8 | -238.37 | -236.24 | -233.29 |
Book Value Per Share | 7.32 | 6.81 | 61.84 | -10.11 | -9.10 | -7.92 |
Tangible Book Value | 819.18 | 625.42 | 748.29 | -122.62 | -110.29 | -96 |
Tangible Book Value Per Share | 7.25 | 6.72 | 61.72 | -10.11 | -9.10 | -7.92 |
Land | - | 105.75 | 105.78 | 13.55 | 13.55 | 13.55 |
Buildings | - | 247.95 | 247.95 | 174.88 | 174.88 | 174.88 |
Machinery | - | 434.5 | 407.66 | 108.93 | 108.93 | 108.93 |